School of Medicine
Showing 1-46 of 46 Results
-
Robert Michael Fairchild
Assistant Professor of Medicine (Immunology and Rheumatology)
Current Research and Scholarly InterestsDr. Fairchild’s research interests center on novel applications of ultrasonography in rheumatologic disease. Current active research endeavors include using ultrasound 1) to evaluate articular and soft tissue manifestations of systemic sclerosis, 2) to screen, detect and monitor of connective tissue disease associated interstitial lung disease, 3) and applying deep learning techniques to rheumatology ultrasound and imaging.
-
Bita Fakhri, MD, MPH
Assistant Professor of Medicine (Hematology)
BioDr. Bita Fakhri is Assistant Professor of Medicine in the Division of Hematology at Stanford University School of Medicine. She specializes in the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), hairy cell leukemia, and other hematologic malignancies. As a clinical scientist, Dr. Fakhri is dedicated to caring for patients, teaching trainees, and researching novel therapies for patients with CLL/SLL. Dr. Fakhri has co-authored numerous publications on topics including CLL, novel targeted agents, and cellular therapies for patients with hematologic malignancies. Currently, Dr. Fakhri is the director of the CLL clinical trial portfolio at Stanford. Additionally, in her role as the DEI ambassador of the Division of Hematology, her main focus is to enhance trial equity among underserved and marginalized populations in the Stanford catchment area.
-
Titilola Falasinnu
Assistant Professor of Medicine (Immunology and Rheumatology) and, by courtesy, of Anesthesiology, Perioperative and Pain Medicine (Adult Pain)
BioI am primarily a lupus researcher and identify as a pain scientist and methodologist in this field. Systemic lupus erythematosus (SLE) disproportionately affects women and racial minorities and is the fifth most common cause of death among 15- to 24-year-old Black and Hispanic women in the U.S., highlighting its significant public health impact. More than half of patients with SLE experience chronic pain, often secondary to SLE itself or overlapping conditions (e.g., migraines, low back pain, fibromyalgia), contributing significantly to disability and impaired quality of life. Chronic pain is not merely a symptom but a disease in its own right—one that deserves the same rigorous study and clinical attention as comorbidities like kidney disease and cardiovascular disease in rheumatology. The enormous global burden of chronic pain underscores the urgent need for a clear, standardized definition of pain as a disease, particularly in autoimmune rheumatic diseases where pain can arise from inflammatory, nociplastic, and biopsychosocial mechanisms. Without recognizing pain as a distinct disease entity, its mechanisms remain poorly understood, and effective treatment strategies remain underdeveloped.
I am a co-Principal Investigator of the Pain Intelligence Lab, where our mission is to advance the study of pain as a disease in rheumatology through two primary objectives. First, we develop and validate computational methods that enable clinicians and researchers to leverage electronic health records, administrative claims, and disease registries to study chronic pain as a distinct disease entity in rheumatology. By applying machine learning, natural language processing, and real-world data analysis, we seek to enhance pain phenotyping, classify distinct pain subtypes, and develop predictive models for treatment response. Second, we use a biopsychosocial framework to examine the predictive power of biomarkers and psychosocial measures in rheumatologic pain. By integrating biological, psychological, and social determinants of pain, we aim to conduct rigorous, patient-oriented research that translates targeted assessments into mechanistically informed, personalized treatment approaches for optimized clinical care. Ultimately, my long term career goal is to bridge the gap between research and clinical practice, ensuring that pain management in autoimmune rheumatic diseases is precise, equitable, and optimized for improved patient outcomes. -
Alice C. Fan
Associate Professor of Medicine (Oncology) and, by courtesy, of Urology
Current Research and Scholarly InterestsDr. Fan is a physician scientist who studies how turning off oncogenes (cancer genes) can cause tumor regression in preclinical and clinical translational studies. Based on her findings, she has initiated clinical trials studying how targeted therapies affect cancer signals in kidney cancer and low grade lymphoma. In the laboratory, she uses new nanotechnology strategies for tumor diagnosis and treatment to define biomarkers for personalized therapy.
-
Diana Farid
Clinical Associate Professor, Medicine - Vaden Health Center
BioDiana Farid MD, MPH is a physician, award-winning author, poet, and filmmaker. She is a staff physician at the Stanford Vaden Health Center and Clinical Associate Professor in the Department of Medicine. She holds a BA in Peace and Conflict Studies from Berkeley, with a concentration in public health, socio-economic development, and human rights. She was awarded a fellowship by the Maternal and Child Health Bureau, U.S. Department of Health and Human Services, to be a Child and Family Health Leadership Fellow at UCLA, where she also earned a Masters in Public Health focused on community health, health communications, and storytelling. She creates and amplifies stories and art to foster health.
As a physician consultant for The Media Project, Advocates for Youth, Diana worked with writers and producers for television shows, such as GREY’S ANATOMY and STRONG MEDICINE, to promote adolescent health through entertainment. Her debut feature length documentary film production, AMERICAN RHYTHMS (2008) (americanrhythmsmovie.com/), explores the positive impact of music on elementary school students.
She has lead or presented at Medical Humanities and Arts programs across Stanford, including annual readings of her original poetry in collaboration with the St. Lawrence String Quartet, leading The Pegasus Writers' "The Body as Temple" curated reading, and leading Medicine and the Muse's annual collaboration with UNAFF, among others. As Assistant Director of Stanford School of Medicine’s Program in Bioethics and Film, she produced film screenings and panel discussions with producers, directors, field experts, Stanford faculty, students, and the community, exploring films with vital bioethical implications. She established the first Stanford Film and Medicine Interest group for medical students to study film as a health promotion tool and has mentored medical student film projects. She produced the Stanford Medicine and the Muse, Medical Humanities and the Arts' 2018 Frankenstein@200 year-long cross-campus film screening and panel series on the personal, cultural, social, and bioethical impact of medical research, technology, and healthcare through the lens of story in film. Currently, she mentors Medical Humanities and Art Faculty Fellows.
Diana’s poems have been presented in anthologies, journals, gallery exhibits, and live story-telling events, including The Nocturnists. Her poem, "Dear Medicine", is part of the seminal 2019 report by the National Academy of Medicine, “Taking Action Against Clinician Burnout”. She is an Editorial Board member of the medical humanities journal, The Pharos.
Her multi-award-winning picture book, WHEN YOU BREATHE, melds respiratory science with poetry. Her multi-award-winning novel, WAVE, noted as “Raw and powerful…Rich, layered and heart-rending” — Kirkus, won the Cybils Award for Novel in Verse and was named a Best Middle Grade Book of 2022 by the School Library Journal. WAVE highlights the power of poetry and music on wellbeing. Her 2024 books, THE LIGHT OF HOME and ALREADY ALL THE LOVE, celebrate home and presence. -
C. Garrison Fathman
Professor of Medicine (Immunology and Rheumatology), Emeritus
Current Research and Scholarly InterestsMy lab of molecular and cellular immunology is interested in research in the general field of T cell activation and autoimmunity. We have identified and characterized a gene (GRAIL) that seems to control regulatory T cell (Treg) responsiveness by inhibiting the Treg IL-2 receptor desensitization. We have characterized a gene (Deaf1) that plays a major role in peripheral tolerance in T1D. Using PBC gene expression, we have provisionally identified a signature of risk and progression in T1D.
-
William Fearon, MD
Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Fearon's general research interest is coronary physiology. In particular, he is investigating invasive methods for evaluating the coronary microcirculation. His research is currently funded by an NIH R01 Award.
-
David Feldman
Professor of Medicine (Endocrinology, Gerontology and Metabolism), Emeritus
Current Research and Scholarly InterestsStudies of the role of the vitamin D receptor in the action of 1,25-dihydroxyvitamin D, the active vitamin D hormone. Current efforts are evaluating the vitamin D receptor in breast and prostate cancer, osteoporosis and rickets.
-
Dean W. Felsher
Professor of Medicine (Oncology) and of Pathology
Current Research and Scholarly InterestsMy laboratory studies the molecular basis of cancer with a focus on understanding when cancer can be reversed through targeted oncogene inactivation.
-
Jessica Ferguson Toll
Clinical Assistant Professor, Medicine - Infectious Diseases
BioDr. Ferguson is a board certified Infectious Disease specialist. She specializes in the treatment of immunocompromised patients, including patients who have undergone bone marrow or solid organ transplantation and patients with hematologic or solid malignancies on chemotherapy.
-
Nielsen Fernandez-Becker
Clinical Professor, Medicine - Gastroenterology & Hepatology
BioI am the director of the Celiac Disease Program at Stanford and I am highly experienced in diagnosis and management of celiac disease and gluten associated disorders.
My objective is to provide excellent and compassionate clinical care for my patients while seeking a better understanding of diseases I treat, particularly Celiac disease (CeD), eosinophilic esophagitis (EoE). My top priorities are patient care and translational research to make new discoveries and improve the care my patients. -
George A. Fisher Jr.
Colleen Haas Chair in the School of Medicine
Current Research and Scholarly InterestsClinical expertise in GI cancers with research which emphasizes Phase I and II clinical trials of novel therapies but also includes translational studies including biomarkers, molecular imaging, tumor immunology and development of immunotherapeutic trials.
-
Peter Fitzgerald, MD, PhD
Professor (Research) of Medicine (Cardiovascular), Emeritus
BioDr. Peter Fitzgerald is the Director of the Center for Cardiovascular Technology and Director of the Cardiovascular Core Analysis Laboratory (CCAL) at Stanford University Medical School. He is an Interventional Cardiologist and has a PhD in Engineering. He is Professor in both the Departments of Medicine and Engineering (by courtesy) at Stanford. Presently, Dr. Fitzgerald’s laboratory includes 17 postdoctoral fellows and graduate engineering students focusing on state-of-the-art technologies in Cardiovascular Medicine. He has led or participated in over 175 clinical trials, published over 550 manuscripts/chapters, and lectures worldwide. He has trained over 150 post-docs in Engineering and Medicine in the past decade. In addition, he heads the Stanford/Asia MedTech innovation program.
Dr. Fitzgerald has been principle/founder of twenty-one medical device companies in the San Francisco Bay Area. He has transitioned fourteen of these start-ups to large medical device companies. He serves on several boards of directors, advised dozens of medical device startups as well as multinational healthcare companies in the design and development of new diagnostic and therapeutic devices in the cardiovascular arena. In 2001, Peter was on the founding team of LVP Capital, a venture firm, focused on medical device and biotechnology start-ups in San Francisco. In 2009, he co-founded TriVentures, which is an incubator/venture fund for early stage medical technology in Israel. -
Annesa Flentje
Professor (Research) of Medicine (Stanford Prevention Research Center)
BioAnnesa Flentje, PhD, is a Professor at Stanford University in the Stanford Prevention Research Center, Department of Medicine, School of Medicine. Dr. Flentje is a clinical psychologist who uses multiple methods to understand the impacts of stress and coping on human health and disease. Her research has investigated how stress directly impacts health outcomes and how these processes are mediated through both behaviors (e.g., substance use and coping) and molecular mechanisms (e.g., epigenetics and transcriptional regulation). Dr. Flentje has developed cognitive behavioral interventions to reduce stress, and identified these as a mechanism to alter immune pathways in gene expression. Dr. Flentje is currently leading a large comparative effectiveness study of two interventions for posttraumatic stress symptoms among LGBTQIA+ populations in California. Dr. Flentje has developed and led nationwide mentoring initiatives to support health research of understudied populations and translational research to improve health. Dr. Flentje is Co-Director of The PRIDE Study (pridestudy.org), a national longitudinal cohort study of LGBTQIA+ individuals within the United States that has enrolled over 30,000 participants and is approaching 10 years of data collection.
-
James Ford
Professor of Medicine (Oncology) and of Genetics and, by courtesy, of Pediatrics
On Partial Leave from 01/01/2025 To 01/01/2026Current Research and Scholarly InterestsMammalian DNA repair and DNA damage inducible responses; p53 tumor suppressor gene; transcription in nucleotide excision repair and mutagenesis; genetic determinants of cancer cell sensitivity to DNA damage; genetics of inherited cancer susceptibility syndromes and human GI malignancies; clinical cancer genetics of BRCA1 and BRCA2 breast cancer and mismatch repair deficient colon cancer.
-
Stephen P. Fortmann, MD
C.F. Rehnborg Professor in Disease Prevention, Emeritus
Current Research and Scholarly InterestsDr. Fortmann's interests include population-level (community) prevention of cardiovascular disease, the epidemiology and prevention of chronic diseases, and the effects of the built environment on health. He has conducted research projects addressing tobacco use cessation, tobacco control policy, the role of retail marketing on youth tobacco use, nutrition education, blood pressure control, and lipid disorders.
-
Virginia Fowkes
Senior Lecturer in Medicine (Family and Community Medicine)
Sr. Research Scholar, Primary Care and Population HealthCurrent Research and Scholarly InterestsEvaluation of academic-community programs for health professionals in medically underserved areas
Training of health professionals for medically underserved areas/populations
Program development in medical education (Family Medicine and (AHECs)
National and state policy workforce development -
Michael B. Fowler, MBBS, FRCP
Professor of Medicine (Cardiovascular), Emeritus
Current Research and Scholarly InterestsAdrenergic nervous system; beta-adrenergic function in, heart failure; drugs in heart failure.
-
Andrea Fox
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioAndrea is a certified Physician Assistant who joined Stanford Health Care in 2019 to develop a comprehensive Fracture Liaison Service and bone health clinic championed by Dr. Michael Gardner, Trauma Orthopaedist. Andrea earned a Masters degree in Medical Science, Physician Assistant Studies and a Masters in Health Administration, both from the University of Missouri. She holds a current certification with the International Society of Clinical Densitometry and has completed her certificate trained as a fracture liaison clinician through the National Osteoporosis Foundation. She has a keen interest in educating primary care providers and the general public on the importance of early monitoring, risk factors and treatment for bone loss and the prevention and healing of fractures.
-
Matthew Frank
Assistant Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
BioDr. Matthew Frank, MD, PhD, is an Assistant Professor of Medicine in the Division of Blood and Marrow Transplantation and Cellular Therapy at Stanford University. Dr. Frank predominantly cares for patients with high-risk lymphoma and other blood cancers. He is a lead investigator of clinical trials evaluating the safety and effectiveness of cancer treatments called chimeric antigen receptor (CAR ) T therapy for patients with lymphomas and leukemias. Dr. Frank’s research focuses on developing methods to identify patients who are at high risk for relapse or developing side-effects after receiving CAR T therapy and to understand why these relapses and side-effects occur.
-
Susan M. Frayne, MD, MPH
Professor of Medicine (General Medical Discipline)
Current Research and Scholarly InterestsPrimary care for mentally ill patients, particularly post-traumatic stress disorder in women seconday to sexual trauma.
-
William James Frederick
Clinical Associate Professor, Medicine
BioDr. William James Frederick III is the Medical Director of Case Management, Utilization Management, and the Physician Advisor Medical Director at Stanford Health Care. Prior to moving to Stanford in August 2023, Dr. Frederick was a Physician Advisor and Clinical Associate Professor of Medicine at UC San Diego Health. As an expert in Healthcare Quality Care Management, he has started internal physician advisor programs, redesigned utilization management workflow, led quality improvement initiatives around readmissions and length of stay, developed a General Inpatient Hospice program, partnered with a critical illness recovery hospital to improve quality and patient care, revamped and expanded health system charity policies, and implemented multidisciplinary team rounding. As a medical educator, Dr. Frederick served as the Course Director for 4th year medical students during inpatient medicine rotations across four hospitals. As an Internal Medicine Core Faculty Member, he instituted a weekly resident quality improvement and patient safety conference. He provided ongoing education to faculty, staff, and trainees on topics of inpatient clinical care, ethical use of hospice, critical illness recovery hospitals, patient flow, and quality management. His desire to give back to the community led him to service as faculty chair of the UC San Diego Faculty and Staff giving council.
Dr. Frederick is board certified in both Internal Medicine and Health Care Quality Management with a sub-certification as a Physician Advisor. He completed his residency at Santa Clara Valley Medical Center and earned both an MD and PhD in Electrical and Computer Engineering from UC Davis. He holds a BS in Bioengineering from UC San Diego. He began his career by serving in the United States Marine Corps as infantryman from 1989-1993. -
Michael Fredericson, MD
Professor of Orthopaedic Surgery and, by courtesy, of Medicine (Stanford Prevention Research Center)
Current Research and Scholarly InterestsMy research focuses on the etiology, prevention, and treatment of overuse sports injuries in athletes and lifestyle medicine practices for improved health and longevity.
-
Shai Friedland
Professor of Medicine (Gastroenterology and Hepatology)
Current Research and Scholarly Interests1. Gastrointestinal Endoscopy- Techniques and Outcomes
2. Noninvasive colorectal cancer screening
3. Medical device development in gastroenterology -
Victor Froelicher, MD
Professor of Medicine (Cardiovascular) at the Veterans Affairs Palo Alto Health Care System, Emeritus
Current Research and Scholarly InterestsScreening of athletes for sudden cardiac death, Computerized ECG and clinical data management; exercise Physiology including expired gas analysis; the effect of chronic and acute exercise on the heart; digital recording of biological signals; diagnostic use of exercise testing; development of Expert Medical System software and educational tools.
-
Eri Fukaya
Clinical Professor, Surgery - Vascular Surgery
Clinical Professor, Medicine - Primary Care and Population HealthBioDr. Fukaya practices Vascular Medicine at the Stanford Vascular Clinics and Advanced Wound Care Center. She received her medical education in Tokyo and completed her medical training both in the US and Japan. She joined Stanford in 2015.
Vascular Medicine covers a wide range of vascular disorders including chronic venous insufficiency, varicose veins, deep vein thrombosis, post thrombotic syndrome, peripheral artery disease, carotid artery disease, cardiovascular risk evaluation, fibromuscular dysplasia, rare vascular disease, lymphedema, arterial/venous/diabetic ulcers, and wound care.
Dr. Fukaya has a special interest in venous disease and started the Stanford Vascular and Vein Clinic in 2016.
Board Certified in Vascular Medicine
Board Certified in Internal Medicine
Board Certified in Internal Medicine (Japan)
Board Certified in Plastic and Reconstructive Surgery (Japan) -
Enrica Fung, MD
Clinical Assistant Professor, Medicine - Nephrology
BioDr. Fung is a board-certified nephrologist with Stanford Health Care’s Kidney Clinic and Kidney and Pancreas Transplant Program. She is also a clinical assistant professor of medicine in the Division of Nephrology.
Dr. Fung cares for people with all types of kidney diseases. After completing her nephrology fellowship at Stanford School of Medicine, Dr. Fung served as chief of nephrology and led the transplant referral and post-transplant program at Veterans Affairs Loma Linda Healthcare System. Her extensive experience includes working with older adults and veterans with advanced or chronic kidney disease. Dr. Fung’s work reflects a passion for educating and empowering her patients. She integrates their goals of care and other aspects of advanced care planning into treatment planning.
Dr. Fung’s clinical research interests broadly include healthcare delivery and health outcomes in chronic kidney disease.
Dr. Fung is a peer reviewer for several prestigious publications, including Kidney Medicine and the American Heart Journal. She has also been featured on podcasts and health care educational videos. She has presented to her peers at the American Society of Geriatrics, the American Society of Nephrology, and the American College of Physicians, Northern California Chapter. Dr. Fung has also published work in the Merck Manual Professional Edition, the American Journal of Kidney Diseases, and the journal of the International Pediatric Nephrology Association.
Dr. Fung is a fellow of the American Society of Nephrology and a member of the American Society of Nephrology.
